Mepred 8 Tablet contains methylprednisolone 8 mg, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is indicated for the management of various conditions including allergic disorders, dermatologic diseases, endocrine disorders, rheumatic diseases, and certain respiratory illnesses. Methylprednisolone exerts its therapeutic effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing inflammation, edema, and tissue damage. The drug is commonly prescribed for acute exacerbations of chronic conditions such as asthma, rheumatoid arthritis, and lupus erythematosus. Mepred 8 Tablet should be used under medical supervision, with dosage tailored according to the severity of the condition and patient response. Caution is advised in patients with infections, diabetes, hypertension, osteoporosis, or peptic ulcer disease due to potential side effects including immunosuppression, hyperglycemia, fluid retention, and gastrointestinal disturbances. Abrupt discontinuation should be avoided to prevent adrenal insufficiency; gradual tapering is recommended after prolonged therapy. Regular monitoring of blood pressure, blood glucose, and electrolyte levels is essential during treatment. Mepred 8 Tablet is contraindicated in systemic fungal infections and known hypersensitivity to corticosteroids. It is a valuable therapeutic agent in managing inflammatory and autoimmune disorders when used judiciously.